Leukocyte telomere length in mastocytosis: Correlations with depression and perceived stress

Brain, Behavior, and Immunity

Volumn 35, Issue , 2014, Pages 51-57

  Georgin Lavialle, Sophie ^a,b   Moura, Daniela Silva ^a   Bruneau, Julie ^a,b   Chauvet Gélinier, Jean Christophe ^c,d   Damaj, Gandhi ^a,e   Soucie, Erinn ^f   Barete, Stéphane ^a,b   Gacon, Anne Laure ^a   Grandpeix Guyodo, Catherine ^a   Suarez, Felipe ^a,b   Launay, Jean Marie ^g   Durieu, Isabelle ^h   Esparcieux, Aurélie ^h   Guichard, Isabelle ⁱ   Sparsa, Agnès ^j   Nicolini, Franck ^h   Gennes, Christian de ^k   Trojak, Benoit ^d   Haffen, Emmanuel ^l   Vandel, Pierre ^l   Lortholary, Olivier ^a   Dubreuil, Patrice ^a,f   Bonin, Bernard ^c,d   Sultan, Serge ^m   Teyssier, Jean Raymond ^c   Hermine, Olivier ^a,b,n   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e AMIENS UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h UNIVERSITÉ LYON 1   (France)

ⁱ HÔPITAL NORD   (France)

^j DUPUYTREN UNIVERSITY HOSPITAL   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^m UNIVERSITY OF MONTREAL   (Canada)

ⁿ CNRS   (France)

more..

Author keywords

Cellular aging; Depression; Mast cell; Negative emotionality; Perceived stress; Telomerase activity; Telomere length

Indexed keywords

TELOMERASE; TRYPTASE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; CHROMOSOME SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; EMOTIONALITY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HUMAN; LEUKOCYTE; MALE; MASTOCYTOSIS; PERCEIVED STRESS; PERCEIVED STRESS SCALE; PRIORITY JOURNAL; STRESS; TELOMERE SHORTENING; WILD TYPE; GENETICS; MENTAL STRESS; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGED; DEPRESSION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MASTOCYTOSIS; MIDDLE AGED; STRESS, PSYCHOLOGICAL; TELOMERE SHORTENING; YOUNG ADULT;

EID: 84888878271     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2013.07.009     Document Type: Article

References (52)

1. Akin C., Valent P., Metcalfe D.D. Mast cell activation syndrome: proposed diagnostic criteria. J. Allergy Clin. Immunol. 2010, 126(1099-1104):e1094.
2. Beck A.T., Steer R.A., Brown G.K. Beck Depression Inventory-Second Edition (BDI-II) 1996, The Psychological Corporation San Antonio, TX.
3. Bienenstock J. Relationships between mast cells and the nervous system. Revue Française d'Allergologie et d' Immunologie Clinique 2002, 42:11-15.
4. Bienenstock J., Tomioka M., Matsuda H., Stead R.H., Quinonez G., Simon G.T., Coughlin M.D., Denburg J.A. The role of mast cells in inflammatory processes: evidence for nerve/mast cell interactions. Int. Arch. Allergy Appl. Immunol. 1987, 82:238-243.
5. Blackburn E.H. Structure and function of telomeres. Nature 1991, 350:569-573.
6. Bodemer C., Hermine O., Palmerini F., Yang Y., Grandpeix-Guyodo C., Leventhal P.S., Hadj-Rabia S., Nasca L., Georgin-Lavialle S., Cohen-Akenine A., Launay J.M., Barete S., Feger F., Arock M., Catteau B., Sans B., Stalder J.F., Skowron F., Thomas L., Lorette G., Plantin P., Bordigoni P., Lortholary O., de Prost Y., Moussy A., Sobol H., Dubreuil P. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J. Invest. Dermatol. 2010, 130:804-815.
7. Bunevicius A., Staniute M., Brozaitiene J., Bunevicius R. Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients. J. Psychosom. Res. 2012, 72:22-25.
8. Castells M., Austen K.F. Mastocytosis: mediator-related signs and symptoms. Int. Arch. Allergy Immunol. 2002, 127:147-152.
9. Cohen S., Kamarch T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
10. Edvinsson L., Cervos-Navarro J., Larsson L.I., Owman C., Ronnberg A.L. Regional distribution of mast cells containing histamine, dopamine or 5-hydroxytryptamine in the mammalian brain. Neurology 1977, 27:878-884.
11. Epel E.S., Blackburn E.H., Lin J., Dhabhar F.S., Adler N.E., Morrow J.D., Cawthon R.M. Accelerated telomere shortening in response to life stress. Proc. Natl. Acad. Sci. USA 2004, 101:17312-17315.
12. Epel E.S., Lin J., Dhabhar F.S., Wolkowitz O.M., Puterman E., Karan L., Blackburn E.H. Dynamics of telomerase activity in response to acute psychological stress. Brain Behav. Immun. 2009, 24:531-539.
13. Esposito P., Gheorghe D., Kandere K., Pang X., Connolly R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 2001, 888:117-127.
14. Georgin-Lavialle S., Aouba A., Mouthon L., Londono-Vallejo J.A., Lepelletier Y., Gabet A.S., Hermine O. The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun. Rev. 2010, 9:646-651.
15. Gilfillan A.M., Austin S.J., Metcalfe D.D. Mast cell biology: introduction and overview. Adv. Exp. Med. Biol. 2011, 716:2-12.
16. Goldschmidt R.C., Hough L.B., Glick S.D., Padawer J. Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymetry. Brain Res. 1984, 323:2096217.
17. Hahn K.A., Ogilvie G., Rusk T., Devauchelle P., Leblanc A., Legendre A., Powers B., Leventhal P.S., Kinet J.P., Palmerini F., Dubreuil P., Moussy A., Hermine O. Masitinib is safe and effective for the treatment of canine mast cell tumors. J. Vet. Intern. Med. 2008, 22:1301-1309.
18. Hamilton M.J., Hornick J.L., Akin C., Castells M.C., Greenberger N.J. Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations. J. Allergy Clin. Immunol. 2011, 128(147-152):e142.
19. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
20. Harley C.B., Vaziri H., Counter C.M., Allsopp R.C. The telomere hypothesis of cellular aging. Exp. Gerontol. 1992, 27:375-382.
21. Hartmann N., Boehner M., Groenen F., Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress. Anxiety 2010, 27:1111-1116.
22. Hermine O., Lortholary O., Leventhal P.S., Catteau A., Soppelsa F., Baude C., Cohen-Akenine A., Palmerini F., Hanssens K., Yang Y., Sobol H., Fraytag S., Ghez D., Suarez F., Barete S., Casassus P., Sans B., Arock M., Kinet J.P., Dubreuil P., Moussy A. Case-control cohort study of patients' perceptions of disability in mastocytosis. PLoS ONE 2008, 3:e2266.
23. Hoen P.W., de Jonge P., Na B.Y., Farzaneh-Far R., Epel E., Lin J., Blackburn E., Whooley M.A. Depression and leukocyte telomere length in patients with coronary heart disease: data from the heart and soul study. Psychosom. Med. 2011, 73:541-547.
24. Mastocytosis (Mast cell disease). World Health Organization (WHO) classification of tumours of hematopoietic and lymphoid tissues 2008, International Agency for Research and cancer (IARC), Lyon. H.P. Horny, D. Metcalfe, J.M. Benett (Eds.).
25. Johnson D., Krenger W. Interactions of mast cells with the nervous system - recent advances. Neurochem. Res. 1992, 17:939-951.
26. Lennert K., Parwaresch M.R. Mast cells and mast cell neoplasia: a review. Histopathology 1979, 3:349-365.
27. Lim K.H., Tefferi A., Lasho T.L., Finke C., Patnaik M., Butterfield J.H., McClure R.F., Li C.Y., Pardanani A. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009, 113:5727-5736.
28. Lustman P.J., Clouse R.E., Griffith L.S., Carney R.M., Freedland K. Screening for depression in diabetes using the beck depression inventory. Psychosom. Med. 1997, 59:24-31.
29. Matsumoto I., Inoue Y., Shimada T., Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J. Exp. Med. 2001, 194:71-78.
30. Metcalfe D.D. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991, 96:2S-4S.
31. Metcalfe D.D. Mast cells and mastocytosis. Blood 2008, 112:946-956.
32. Moura D.S., Sultan S., Georgin-Lavialle S., Barete S., Lortholary O., Gaillard R., Hermine O. Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS ONE 2012, 7:e39468.
33. Moura D.S., Sultan S., Georgin-Lavialle S., Pillet N., Montestruc F., Gineste P., Barete S., Damaj G., Moussy A., Lortholary O., Hermine O. Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy. PLoS ONE 2011, 6:e26375.
34. O'Donovan A., Lin J., Dhabhar F.S., Wolkowitz O., Tillie J.M., Blackburn E., Epel E. Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav. Immun. 2009, 23:446-449.
35. Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr. Drug Targets Inflamm. Allergy 2005, 4:517-519.
36. Orfao A., Garcia-Montero A.C., Sanchez L., Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br. J. Haematol. 2007, 138:12-30.
37. Paul C., Sans B., Suarez F., Casassus P., Barete S., Lanternier F., Grandpeix-Guyodo C., Dubreuil P., Palmerini F., Mansfield C.D., Gineste P., Moussy A., Hermine O., Lortholary O. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study. Am. J. Hematol. 2010, 85:921-925.
38. Rogers M.P., Bloomingdale K., Murawski B.J., Soter N.A., Reich P., Austen K.F. Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosom. Med. 1986, 48:437-447.
39. Schwartz L.B., Bradford T.R., Rouse C., Irani A.M., Rasp G., Van der Zwan J.K., Van der Linden P.W. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J. Clin. Immunol. 1994, 14:190-204.
40. Shaffer J.A., Epel E., Kang M.S., Ye S., Schwartz J.E., Davidson K.W., Kirkland S., Honig L.S., Shimbo D. Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based study. PLoS ONE 2012, 7:e48318.
41. Simon N.M., Smoller J.W., McNamara K.L., Maser R.S., Zalta A.K., Pollack M.H., Nierenberg A.A., Fava M., Wong K.K. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol. Psychiatry 2006, 60:432-435.
42. Sokol H., Georgin-Lavialle S., Grandpeix-Guyodo C., Canioni D., Barete S., Dubreuil P., Lortholary O., Beaugerie L., Hermine O. Gastrointestinal involvement and manifestations in systemic mastocytosis. Inflamm. Bowel Dis. 2010, 16:1247-1253.
43. Sperr W.R., Jordan J.H., Baghestanian M., Kiener H.P., Samorapoompichit P., Semper H., Hauswirth A., Schernthaner G.H., Chott A., Natter S., Kraft D., Valenta R., Schwartz L.B., Geissler K., Lechner K., Valent P. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001, 98:2200-2209.
44. Theoharides T. Autism spectrum disorders and mastocytosis. Int. J. Immunopathol. Pharmacol. 2009, 22:859-865.
45. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 1990, 46:607-617.
46. Theoharides T.C., Pang X., Letourneau R., Sant G.R. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann. N. Y. Acad. Sci. 1998, 840:619-634.
47. Theoharides T.C., Spanos C., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G.P. Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 1995, 136:5745-5750.
48. Mastocytosis (Mast cell disease). World Health Organization (WHO) classification of tumours 2001, IARC Press, Lyon, France. P. Valent, H.-P. Horny, L. Escribano, B.J. Longley, C.Y. Li, L.B. Schwartz (Eds.).
49. Valent P., Horny H.P., Escribano L., Longley B.J., Li C.Y., Schwartz L.B., Marone G., Nunez R., Akin C., Sotlar K., Sperr W.R., Wolff K., Brunning R.D., Parwaresch R.M., Austen K.F., Lennert K., Metcalfe D.D., Vardiman J.W., Bennett J.M. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk. Res. 2001, 25:603-625.
50. Warmenhoven F., van Rijswijk E., Engels Y., Kan C., Prins J., van Weel C., Vissers K. The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients. Support. Care Cancer 2012, 20:319-324.
51. Wolfreys K., Oliveira D.B. Alterations in intracellular reactive oxygen species generation and redox potential modulate mast cell function. Eur. J. Immunol. 1997, 27:297-306.
52. Wolkowitz O., Epel E.S., Reus V.I., Mellon S.H. Depression gets old fast: do stress and depression accelerate cell aging. Depress. Anxiety 2010, 27:327-338.